Pfizer on Tuesday announced a cancer drug licensing deal with Chinese biotech 3SBio that includes a $1.25 billion upfront ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Roivant has its own TYK2/JAK1 inhibitor in development in the form of brepocitinib, which the biopharma licensed from Pfizer ...

ReproNovo raises $65M for trials of leflutrozole and nolasiban in reproductive health. CEO Jean Marie Duvall plans Phase 2 ...

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.

Plenty of questions remain about Trump's plan to push U.S. drug prices down closer to those in other countries.

Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug ...

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...

Development of deep expertise in one specific drug class PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) is a biotechnology company focused on the research, development, and manufacturing ...

President Donald Trump signed an executive order Monday that he said will slash drug prices by approximately 59% or more ...

President Donald Trump's plan to change the pricing model for some medications is already facing fierce criticism from the ...